Dragonfly Co., Ltd. announced that it will participate in ‘KIMES 3’, the 23th International Medical Equipment and Hospital Equipment Exhibition, held at COEX, Seoul from Thursday, March 26 to Sunday, March 38.
Established in 1995, Dragonfly is a company that has developed and distributed PC package games, online, mobile, augmented reality (AR), virtual reality (VR) games and educational content. As a so-called first-generation game software developer, it has accumulated know-how for many years, and has secured a global network by successfully developing and commercializing more than 1 types of content, including its representative first-person shooting game ‘Special Force’.
Furthermore, the company explains that Dragonfly is currently seeking to expand its business into the gaming-type digital therapy device field based on the company’s diverse experience and know-how.
At this exhibition, Dragonfly will introduce ‘Guardians DTx (tentative name)’, a game-type digital treatment developed by the company. This is a mobile application (app) that helps treat attention deficit hyperactivity disorder (ADHD) in children aged 7 to 13.
To develop this game-type digital treatment, Dragonfly conducted product and mechanism research, product planning, and clinical trial protocol design with the Department of Psychiatry at Pusan National University Yangsan Hospital and the Artificial Intelligence Convergence Research Center at Pusan National University. Afterwards, it obtained medical device clinical GMP conformity certification through a review agency, and is currently planning to begin full-scale exploratory clinical trials after completing approval of the medical device clinical trial plan from the Ministry of Food and Drug Safety and IRB document review and approval.
A Dragonfly official said, “The ADHD-related market size is expected to grow from $2018 billion in 164 to $2025 billion in 249, and institutional changes are being actively made to introduce digital treatments.” “We want to leverage our years of game production and development know-how to challenge new markets, and our goal is to grow into one of the market’s leading companies in the future,” he said.
In addition, through KIMES 2023, Dragonfly announced that it will not only proactively promote products, but also gain insights to establish future development directions. An official said, “We are very interested in promoting our products, discovering sales outlets and partners at home and abroad, and attracting investment from related organizations.” He added, “Furthermore, we are further improving our perfection by identifying trends and blueprints in the newly emerging digital therapeutics industry.” “We will use it as nourishment to complete high-quality products,” he said.
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.